Patients with herpes zoster can develop persistent pain after rash healing, a complication
known as postherpetic neuralgia. By preventing zoster through vaccination, the risk of this …

Herpes zoster, also known as shingles, is a distinctive clinical condition caused by the
reactivation of latent varicella zoster (chickenpox) virus following an initial infection …

Background A trial involving adults 50 years of age or older (ZOE-50) showed that the
herpes zoster subunit vaccine (HZ/su) containing recombinant varicella–zoster virus …

We report the first nationwide survey of the impact of neuropathic pain, as opposed to
nonneuropathic pain, on quality of life and health care utilization in the French general …

Abstract Purpose of Review Transcutaneous electrical nerve stimulation (TENS) is widely
used as a non-pharmacological approach for pain relief in a variety of clinical conditions …

Background The EQ-5D is a preference based instrument which provides a description of a
respondent's health status, and an empirically derived value for that health state often from a …

Objective: To investigate risk factors for postherpetic neuralgia, the neuropathic pain that
commonly follows herpes zoster. Methods: Using primary care data from the Clinical …

The objective of this chapter is to review the epidemiology and natural history of herpes
zoster and postherpetic neuralgia. Epidemiology seeks to explain and comprehend …

Understanding the effect of herpes zoster and zoster-related pain should inform care to
improve health-related quality of life in elderly patients. A 12-month, longitudinal …

Herpes zoster and its sequela post-herpetic neuralgia (PHN) are conditions with significant
morbidity. PHN is a chronic, debilitating neuropathic pain that can persist long beyond …